How to Buy Silence Therapeutics Stock

Silence Therapeutics PLC

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications.

Silence Therapeutics stock last closed at $3.70, up 8.82% from the previous day, and has decreased 83.07% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Silence Therapeutics stock is currently +87.82% from its 52-week low of $1.97, and -84.82% from its 52-week high of $24.38.

At the moment, there are 141.67M SLN shares outstanding. The market cap of SLN is $174.56M. In the last 24 hours, 132,882 SLN shares were traded.

How to Buy Silence Therapeutics Stock

Wondering how to invest in Silence Therapeutics stock? Here's how.

  1. Choose where to buy Silence Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Silence Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your brokerage account: Pick your payment method and add your info.
  4. Analyze Silence Therapeutics stock: The Silence Therapeutics ticker symbol is SLN. Is Silence Therapeutics stock a good investment? Should you buy shares of SLN? How do SLN's underlying business fundamentals look? Do top analysts think Silence Therapeutics is a good buy? Why has SLN's stock price moved recently? (Hint: Our stock market research tools can help you figure out if SLN is a good stock to buy).
  5. Execute your SLN buy order: Decide if you will purchase SLN shares at the current market price or use a limit order to purchase SLN shares at a particular price.
  6. Track your investment in SLN: Create a watchlist to key updates about your position in Silence Therapeutics shares.

Step 1: Choose where to buy Silence Therapeutics stock

You will need a brokerage account in order to access the NASDAQ market and buy SLN shares.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our research, eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in SLN today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to start a new brokerage account.
  1. Send your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you've finished signing up on stock market app, you can securely and quickly fund your account:

Watch the tutorial below for more details transferring funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Silence Therapeutics stock

After you have identified the best place to buy Silence Therapeutics stock, it's crucial to research their stock before you invest, so you can understand the risk and opportunity.

Silence Therapeutics Numbers

SLN Price
$3.70
1w %
11.45%
1y %
-83.07%
5y %
N/A
P/E
-3.74x
P/B
-1.3x
P/S
3.96x
PEG
N/A
Revenue
$43.26M
Earnings
-$45.31M
Fore. Rev. Growth
61.09%
Fore. Earn. Growth
N/A
Market Cap
$174.56M
Next Earnings
N/A
Next Dividend
N/A

Silence Therapeutics Due Diligence Checks

WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on SLN's stock page.

Is SLN stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge SLN's true value.

You can do more valuation analysis on SLN's stock here.

SLN Financials at a glance

Positive Financial Indicators:

  • There are more short-term assets than short-term liabilities on the SLN balance sheet.
  • There are more short-term assets than long-term liabilities on the SLN balance sheet.
  • SLN has $147.33M in cash and short term investments. This is enough to cover its annual cash burn of $67.85M.
  • SLN has cash burn of 67851000. It has enough cash and short-term investments to cover this for at least one year.

Negative Financial Indicators:

  • SLN profit margin has gone up by 0.67 percentage points in the past year, but the company is still unprofitable.
  • Total SLN debt is still negative.
  • SLN debt to equity ratio of -0.51 is negative.

Is it a good time to buy Silence Therapeutics stock, according to Wall Street analysts?

Out of 5 Equities analysts who research SLN, the consensus analyst rating on Silence Therapeutics is a Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Silence Therapeutics stock forecast page.

SLN Technicals

SMA10
3.31
SMA20
2.92
SMA50
3.65
SMA100
4.88
SMA200
10.99
MACD
0
MACD Signal
-0.15
MACD Histogram
0.16
RSI
58.76
Stochastic %K
90.72
Stochastic %D
88.88
StochRSI %K
95.83
StochRSI %D
94.45

SLN Performance Metrics

Last year, SLN revenue was $43.26M. During the last 5 year, SLN's revenue has gone up by 169.37% per year. This was faster than the Biotechnology industry average of 45.66%.

Learn more about SLN's earnings and revenue performance here.

What are SLN insiders up to?

In the past 12 months, executives and large shareholders at SLN have not bought or sold any shares.

Get more info about who owns SLN stock here.

Can I rely on SLN as an income stream?

No, Silence Therapeutics doesn't provide an income stream by paying out dividends.

SLN Social Trading Data

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Execute your SLN buy order

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are generally fine.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.

Press the Open button and your broker will execute your order.

If you want additional help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Track your investment in SLN

Now that you own some SLN stock, you'll want to keep up with your company.

Start a watchlist to track the most important metrics related to your SLN stock.

SLN Feed

How to Buy Stock in Silence Therapeutics

To summarize, here are the 6 steps to buy Silence Therapeutics stock:

  1. Choose where to buy Silence Therapeutics stock
  2. Open your brokerage account
  3. Put funds into your brokerage account
  4. Analyze Silence Therapeutics stock
  5. Execute your SLN buy order
  6. Track your investment in SLN

If you are looking for a online brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get updates on your investment in Silence Therapeutics, click below.

NASDAQ: SLN
$3.70+0.30 (+8.82%)
Updated Apr 30, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: SLN
$3.70+0.30 (+8.82%)
Updated Apr 30, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Silence Therapeutics share?

As of Apr 30, 2025, it costs $3.70 to buy one share of Silence Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.27 shares of SLN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Silence Therapeutics stock?

According to 5 Wall Street analysts who monitor Silence Therapeutics, their consensus recommendation is to buy Silence Therapeutics stock.

What is the best way to buy Silence Therapeutics stock?

One way to place an order for Silence Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.